We rely on polymerase chain reaction testing (PCR) for the most rapid, specific and sensitive testing available for HIV and HSV diagnosis. Our focus on clinically relevant targets means you get exactly the data you need to aid in diagnosis. Our extensive menu of women’s health test offerings makes adherence to national testing guidelines easy.
Disease
Testing Guidelines
PeaceHealth Laboratories Tests
Chlamydia
CDC:
Routine screening of all sexually active women aged = 25 years
Routine screening should occur whether or not patient is pregnant
68363 / LAB2050 CT & GC, TMA Amplified
68360 / LAB2051 CT, TMA Amplified
Gonorrhea
CDC:
Screening recommended for all young, sexually active women, including those who are pregnant
Those with individual or population risk factors should also be screened
68363 / LAB2050 CT & GC, TMA Amplified
68362 / LAB2455 GC, TMA Amplified
Cervical Cancer
ACOG:
First cervical cancer screening at age 21
Screening every two years for women <30
Screening every three years for women >30
70072 ThinPrep Pap
70066 ThinPrep Pap with HPV*
70062 SurePath Pap
70091 SurePath Pap with HPV*
*ThinPrep and SurePath testing for HPV >/+ 30 yr, HPV if ASCUS, and HPV if abnormal also available.
HIV
U.S. Preventive Services Task Force:
Routine screening for all adolescents and adults at increased risk for HIV infection
All pregnant women should be screened for HIV
42040 / LAB918 HIV-1 RNA PCR, Ultra Sensitive 3
42300 / LAB6515 HIV Ag/Ab 4th Generation, Reflex to Confirmation
42655 / LAB6517 HIV-1/2 Ag/Ab Rapid Reflex to HIV Ag/Ab (4th Gen) if reactive
HSV
U.S. Preventive Services Task Force:
Patients who are clinically symptomatic
58450 / LAB2611 HSV by Real-Time Polymerase Chain Reaction (PCR)